Jenburkt Pharmaceuticals Ltd.

Web: jenburkt.com NSE: JENBURPH BSE: 524731 SECTOR: Healthcare - Pharmaceuticals & Biotechnology | Add Note | View Notes

1030 1(0%)

Near 52W High of 1074

Volume

Open

1,203

High

1,222

Low

1,197

1,032

VWAP

52 Week High

1,074

52 Week Low

1,010

Viand Research Rating

Quality Score

28/100

Growth Score

18/100

Valuation Score

50/100

Momentum Score

0/100

Analyst Recommendations

BUY/SELL

Hold | Buy | Strong Buy

Analyst Price Target

Market Cap (cr)

455

No. of Shares

0.44

P/E

17.93

P/B

3.75

Face Value

Div. Yield

Book Value (TTM)

CASH

DEBT

EPS (TTM)

ROE

20.91

ROCE

Profit Growth

Listing Date

Promoter Holding

46.62%

FII Holding

DII Holding

0.12%

Price Chart

Price Performance

1 Week0

1 Month0

3 Months0

6 Months0

1 Year0

YTD0

Moving Average

5 Day SMA0

10 Day SMA0

20 Day SMA0

30 Day SMA0

50 Day SMA0

61 Day SMA0

80 Day SMA0

200 Day SMA0

PIVOT LEVEL

	Standard	Camarilla	Fibonacci	Woodie's
Resistance 3
Resistance 2
Resistance 1
Pivot Point
Support 1
Support 2
Support 3

Competitors/Peers

#	Symbol	MCAP	LTP	1W	1M	6M	1Y	P/E	Ind PE	Debt/Eq	NP Qtr Rs.Cr.
1	SUNPHARMA	4,56,655	1899	0%	2%	9%	21%	37	57.7	0.07	11509
2	DIVISLAB	2,43,196	9161	2%	8%	44%	51%	69	57.7	0	2568
3	TORNTPHARM	1,84,303	4846	2%	3%	12%	36%	72	57.7	1.79	2138
4	APOLLOHOSP	1,24,834	8650	1%	1%	12%	10%	58	57.7	0.9	2003
5	ZYDUSLIFE	1,12,897	1132	4%	2%	26%	13%	20	57.7	0.46	5124
6	CIPLA	1,11,346	1385	2%	5%	3%	12%	22	57.7	0.02	3862
7	LAURUSLABS	99,634	1844	3%	3%	75%	114%	0	57.7	0.48	890
8	DRREDDY	96,962	1151	2%	2%	11%	8%	20	57.7	0.2	4158
9	MAXHEALTH	96,646	985	1%	10%	8%	14%	0	57.7	0.32	1442
10	LUPIN	96,620	2113	1%	11%	8%	10%	23	57.7	0.29	5355
Load More

Shareholding Pattern (%)

	Jun 2026	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024	Jun 2024	Mar 2024	Dec 2023	Sep 2023	Jun 2023	Mar 2023	Dec 2022	Sep 2022	Jun 2022	Mar 2022	Dec 2021
Promoters	(0.01) 46.62%	(0.01) 46.64%	(0.01) 46.65%	(0.01) 46.66%	(0.01) 46.67%	(0.01) 46.68%	(0.01) 46.69%	(0.01) 46.71%	(-0.51) 46.71%	(-0.21) 47.23%	(0.01) 47.39%	(-0.11) 47.42%	(0.01) 47.56%	(1.61) 47.56%	(0.21) 45.96%	(0.01) 45.74%	(0.01) 45.73%	(0.01) 45.73%	(0.01) 45.73%
FIIs	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%	(-1.41) 0.00%	(-0.41) 1.38%	(-0.91) 1.79%	(-0.81) 2.70%	(-1.31) 3.49%	(0.41) 4.79%	(0.01) 4.37%	(0.01) 4.37%	(0.01) 4.37%
DIIs	(0.01) 0.12%	(0.01) 0.12%	(0.01) 0.12%	(0.01) 0.12%	(0.01) 0.12%	(0.01) 0.12%	(0.11) 0.12%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%
Public	53.27%	53.24%	53.24%	53.22%	53.21%	53.20%	53.20%	53.28%	53.29%	52.78%	52.63%	51.21%	50.65%	49.73%	50.52%	49.48%	49.90%	49.90%	49.90%
No. of Shareholders	7,103	6,999	7,163	6,855	6,712	6,987	6,901	6,628	6,419	6,316	6,021	5,872	5,741	5,611	5,784	5,896	6,016	6,053	6,116

Quarterly Results

	Jun 2026	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024	Jun 2024	Mar 2024	Dec 2023	Sep 2023	Jun 2023	Mar 2023	Dec 2022	Sep 2022	Jun 2022	Mar 2022	Dec 2021	Sep 2021
Sales	35.51	44.63	43.02	45.56	35.53	41.05	36.89	41.22	32.54	38.84	35.66	38.29	29.18	35	34.57	36	31.13	28.29	33	35.51
Sales Growth % (YoY)	-0.1%	8.7%	16.6%	10.5%	9.2%	5.7%	3.4%	7.6%	11.5%	10.3%	3.2%	6.8%	-6.3%	-	4.8%	1%	14.5%	-4.3%	3.7%	16.5%
Sales Growth % (QoQ)	-20.4%	3.7%	-5.6%	28.2%	-13.4%	11.3%	-10.5%	26.7%	-16.2%	8.9%	-6.9%	31.2%	-16.6%	1.2%	-4%	15.6%	10%	-14.3%	-7.1%	-
Expenses	29.48	30.38	35.59	32.45	26.58	30.19	28.07	29.79	23.26	28.99	28.47	29.19	22.22	28	27.59	27	23.85	23.64	26.03	25.24
Operating Profit	6.03	14.25	7.43	13.11	8.95	10.86	8.82	11.43	9.28	9.85	7.19	9.1	6.96	7	6.98	9	7.28	4.65	6.97	10.27
OPM %	16.98	31.93	17.27	28.78	25.19	26.46	23.91	27.73	28.52	25.36	20.16	23.77	23.85	21	20.19	24	23.39	16.44	21.12	28.92
Other Income	1.51	0.4	1.82	2.08	2.06	1.88	1.58	1.85	1.41	1.19	1.35	1.1	1.04	1	1.46	1	1.14	1.28	1.29	1.19
Interest	0.13	0.13	0.12	0.11	0.11	0.11	0.11	0.12	0.11	0.06	0.07	0.07	0.07	0	0.1	0	0.09	0.12	0.1	0.11
Depreciation	0.64	0.81	0.83	0.74	0.72	0.79	0.78	0.64	0.52	0.62	0.63	0.59	0.5	1	0.58	1	0.54	0.54	0.47	0.45
Profit before tax	6.77	13.71	8.3	14.34	10.18	11.84	9.51	12.52	10.06	10.36	7.84	9.54	7.43	8	7.76	9	7.79	5.27	7.69	10.9
Tax %	13	20.86	28.55	29.08	23.48	27.87	31.65	23.32	26.34	23.94	31.12	23.27	27.73	21	29.9	26	23.62	34.54	18.99	26.88
Net Profit	5.89	10.85	5.93	10.16	7.79	8.54	6.51	9.6	7.42	7.88	5.4	7.32	5.37	6	5.43	7	5.95	3.45	6.23	7.97
Net Profit Growth % (QoQ)	-45.7%	83%	-41.6%	30.4%	-8.8%	31.2%	-32.2%	29.4%	-5.8%	45.9%	-26.2%	36.3%	-10.5%	10.5%	-22.4%	17.6%	72.5%	-44.6%	-21.8%	-
Net Profit Growth % (YoY)	-24.4%	27%	-8.9%	5.8%	5%	8.4%	20.6%	31.1%	38.2%	31.3%	-0.6%	4.6%	-9.7%	73.9%	-12.8%	-12.2%	-	-	-	-
TTM Net Profit	32.83	34.73	32.42	33	32.44	32.07	31.41	30.3	28.02	25.97	24.09	24.12	23.8	24.38	21.83	22.63	23.6	17.65	14.2	0
EPS in Rs	13.35	24.58	13.44	23.02	17.65	19.35	14.75	21.75	16.81	17.86	12.24	16.59	12.17	14.39	11.83	14.97	12.96	7.52	13.57	17.37

Profit and Loss

	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015	Mar 2014	Mar 2013
Sales	169	152	142	137	124	109	119	123	115	103	94	85	76	69
Sales Growth %	11.2%	6.8%	3.8%	10.3%	13.4%	-8.1%	-3.1%	7%	11%	10.4%	9.8%	11.8%	9.9%	15.9%
Expenses	125	111	109	106	97	89	99	98	91	84	77	70	65	59
Operating Profit	44	40	33	30	27	20	20	25	24	20	16	15	12	10
OPM %	26	27	23	22	22	18	17	20	21	19	18	18	15	15
Other Income	6	7	5	5	5	4	4	3	3	3	3	2	2	1
Interest	0	0	0	0	0	0	1	0	0	0	0	0	1	1
Depreciation	3	3	2	2	2	2	2	1	2	2	2	3	2	1
Profit before tax	47	44	35	33	30	22	21	27	25	20	17	14	10	9
Tax %	25	27	26	25	25	24	30	26	32	34	36	33	27	30
Net Profit	35	32	26	25	22	16	15	20	17	14	11	10	8	6
Net Profit Growth %	9.4%	23.1%	4%	13.6%	37.5%	6.7%	-25%	17.6%	21.4%	27.3%	10%	25%	33.3%	-
EPS in Rs	78.72	72.64	58.87	55.76	48.59	35.95	32.4	43.14	37.5	29.06	23.19	20.76	16.15	13.38
Dividend Payout %	26	25	26	26	25	28	25	24	24	28	31	30	32	31

Cash Flows

	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015	Mar 2014	Mar 2013
Cash from Operating Activity	27	28	8	17	9	19	15	13	16	10	8	9	11	5
Cash from Investing Activity	-19	-17	-1	3	-1	-19	-3	-11	1	-10	0	1	0	-1
Cash from Financing Activity	-9	-8	-7	-21	-6	-1	-11	-2	-18	1	-5	1	-7	0
Net Cash Flow	-2	3	0	-1	3	0	1	0	-1	1	2	11	5	3

Balance Sheet

	Mar 2026	Sep 2025	Mar 2025	Sep 2024	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015	Mar 2014	Mar 2013
Equity Capital	4	4	4	4	4	4	5	5	5	5	5	5	5	5	5	5
Reserves	193	178	167	153	141	118	113	94	75	73	57	50	36	29	23	18
Borrowings	2	2	4	2	0	3	7	5	3	7	0	6	5	7	2	5
Other Liabilities	26	24	19	22	19	16	18	17	21	18	16	16	12	21	15	22
Total Liabilities	225	209	195	181	164	141	143	120	104	103	77	76	58	61	44	49
Fixed Assets	19	14	15	14	10	10	11	11	12	10	10	11	12	12	14	14
CWIP	46	52	40	0	1	1	0	0	0	1	0	0	0	0	0	0
Investments	27	27	21	32	17	11	8	7	4	5	5	2	1	0	0	0
Other Assets	132	116	120	135	136	119	123	103	88	87	62	64	45	49	30	34
Total Assets	225	209	195	181	164	141	143	120	104	103	77	76	58	61	44	49

Delivery

Delivery Data: JENBURPH

#	Date	1010 6% 1074	Q/T 41	Del 79
1	4-Sep	1039	11	90
2	3-Sep	1032	74	98
3	2-Sep	1044	15	84
4	1-Sep	1048	62	100
5	31-Aug	1051	20	80
6	28-Aug	1048	9	58
7	27-Aug	1033	13	86
8	26-Aug	1050	13	99
9	25-Aug	1046	50	98
10	24-Aug	1044	19	82
11	21-Aug	1028	13	89
12	20-Aug	1046	20	90
13	19-Aug	1054	12	75
14	18-Aug	1047	7	82
15	17-Aug	1045	18	75

Daily Market Cap

Date	Total Market Cap	Change	Chg %
04-Sep	455c	31L	0.07
03-Sep	455c	9c	1.89
01-Sep	464c	4c	0.93
31-Aug	460c	3c	0.70
27-Aug	456c	13c	2.72
26-Aug	469c	3c	0.64
25-Aug	472c	11c	2.40
24-Aug	461c	2c	0.51
19-Aug	464c	8c	1.63
18-Aug	471c	10c	2.15
17-Aug	461c	0	0

Stock Checklist

Price is above from 52 week high low average: 32%

Stock is trading above all short term SMAs: NO

Stock is trading above all long term SMAs: NO

Stock is Consistently Improving Long Term: NO

FII purchased in last quarter: NO

Promoters are buying the stock: NO

Mutual Fund Holdings

No mutual fund holding data available.

Strategy Builder

Bulk Deals

Events

News

Exchange Filings

Annual Reports

Ratings & Research Reports

Concalls

Announcements

Corporate Announcements

NseIndia | Trendlyne | Screener | TradingView